|Back to main|
CME Group’s Estimates Boosted at Morgan Stanley (CME)
6/30/2010 9:16:00 AM
Futures exchange operator CME Group Inc. ( CME ) on Wednesday saw its earnings estimates raised by analysts at Morgan Stanley.
The firm said it lifted its estimates for CME through 2012, citing higher trading volumes - with the exception of commodities and energy. Morgan Stanley currently rates the stock as "Underweight" with a $319 price target. That target represents a potential 11% upside to CME's Tuesday closing price of $287.91.
CME shares rose $3.59, or +1.3%, in premarket trading Wednesday.
The Bottom Line
CME Group Inc. ( CME ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.